On March 5, 2024 Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, reported that CEO Dr. Adi Mor will deliver a corporate presentation and participate in investor meetings at the Leerink Partners Global Biopharma Conference, March 11-13, 2024 in Miami, Florida (Press release, Chemomab, MAR 5, 2024, View Source [SID1234640773]). Dr. Mor’s presentation will be webcast live and will be available at the investor relations section of the Chemomab website for 90 days.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Leerink Partners Global BioPharma Conference
Date:
March 12, 2024
Time:
10:40am ET
Venue:
Fontainebleau Hotel
Format:
Live presentation and webcast
Webcast Link:
Information: